Orthocell Reports Record Revenue Amid US Expansion

Orthocell Ltd (ASX:OCC) reported record quarterly revenue of A$3.8 million and full-year revenue of A$13.2 million, driven by the adoption of its Remplir™ nerve repair device in Australia and international markets including the United States.

By Proactive Sat, July 18, 2026 at 4:00 AM GMT+3 6 min read · Yahoo Finance · July 18, 2026, 01:00 UTC

Orthocell Reports Record Revenue Amid US Expansion

Topics: expansion revenue US market

Read the full article at Yahoo Finance

More World news

HSBC Developing Risk Transfer Deals for $7 Billion in US and Asian Corporate Loans Seeking Alpha · November 12, 2026, 14:42 UTC
Fundstrat's Tom Lee Views Tech Sell-off as Buying Opportunity Despite Nvidia Leadership Scandal CNBC · November 12, 2026, 14:38 UTC
CytoDyn Secures $5 Million Private Placement for Leronlimab Development Seeking Alpha · November 12, 2026, 14:38 UTC
Cohen & Company Reports Q3 Earnings Miss on Declining Revenue and EPS Seeking Alpha · November 12, 2026, 14:39 UTC
Jensen Huang Resigns as Nvidia CEO Amid Investigation into Foreign Intelligence Allegations Motley Fool · November 12, 2026, 14:39 UTC
SuperCom Reports Q3 Fiscal 2026 Earnings Beat on Revenue and EPS Seeking Alpha · November 12, 2026, 14:35 UTC
Marvell Technology Appoints Three Independent Directors Prior to Proposed Lumentum Acquisition Seeking Alpha · November 12, 2026, 14:35 UTC
M-tron Industries Reports Q3 2026 GAAP EPS Miss Amid Low Revenue Seeking Alpha · November 12, 2026, 14:37 UTC
Nexxen International Reports Q3 Earnings Beat with Revenue Growth and Increased EBITDA Seeking Alpha · November 12, 2026, 14:30 UTC
Brookfield Corporation Announces Quarterly Dividend of $0.07 Per Share Seeking Alpha · November 12, 2026, 14:30 UTC